MAJI — Nextel Medical Corp.
—
OTC ·
Communication Services ·
Wireless Telecommunication Services ·
CIK 1492448 ·
Last close
$0.01
Market Cap
$550.9K
52W High
$0.05
52W Low
$0.01
ADV30
1,387,967
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$-12,830
EBITDA
—
Free Cash Flow
—
Enterprise Value
$1,027,585
Total Cash
$9,010
Total Debt
$714,229
Shares Out
68,860,970
Trailing EPS
$-0.02
Book Value
$-0.02
ROE
—
ROA
—
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IOTR | iOThree Ltd | $2.41M | $3.28 | — |
| KTEL | KonaTel, Inc. | $7.26M | $0.17 | — |
| OBAI | Our Bond, Inc. | $13.21M | $0.54 | — |
| AEHL | Antelope Enterprise Holdings Ltd | $16.22M | $1.04 | — |
| FABC | Fabric.AI, Inc. | $18.16M | $3.74 | — |
News headlines (Yahoo Finance, 1h cache)
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
2026-06-09 11:00 · Yahoo
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
2026-06-02 15:23 · Yahoo
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
2026-05-11 15:53 · Yahoo
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test
2026-04-07 14:30 · Yahoo
Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value
2026-03-16 14:15 · Yahoo
Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions
2026-03-05 18:00 · Yahoo
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
2026-02-10 15:30 · Yahoo
Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization
2025-12-11 17:15 · Yahoo
Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement
2025-12-05 16:00 · Yahoo
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
2025-12-02 18:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.